ReviewJournal of obesity & metabolic syndrome2019

The Effects of Hypoglycemic Agents on Non-alcoholic Fatty Liver Disease: Focused on Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.

Chan-Hee Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.